MMP13 and ductal breast carcinoma in situ: Our previous studies of human DCIS with early invasion led us to hypothesize that MMP13 would be a fibroblast-derived, potential rate-limiting proteinase in the transition from non-invasive to invasive breast carcinoma [12].